$AVY
Avery Dennison Corp Stock $avy

$avy Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000000881824000009 Filed on April 30, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$2.235B	$2.151B
YoY Change	8.25%
Cost Of Revenue	$1.573B	$1.519B
YoY Change	3.28%
Gross Profit	$662.7M	$632.2M
YoY Change	22.2%
Gross Profit Margin	29.65%	29.39%
Selling, General & Admin	$373.9M	$365.2M
YoY Change	11.81%
% of Gross Profit	56.42%	57.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$78.60M	$49.00M
YoY Change	75.45%
% of Gross Profit	11.86%	7.75%
Operating Expenses	$400.9M	$365.2M
YoY Change	19.89%
Operating Profit	$261.8M	$267.0M
YoY Change	25.93%
Interest Expense	-$29.20M	$28.60M
YoY Change	-210.61%
% of Operating Profit	-11.15%	10.71%
Other Income/Expense, Net	$5.800M	$8.600M
YoY Change	26.09%
Pretax Income	$238.4M	$234.4M
YoY Change	41.65%
Income Tax	$61.60M	$62.00M
% Of Pretax Income	25.84%	26.45%
Net Earnings	$176.8M	$172.4M
YoY Change	45.87%
Net Earnings / Revenue	7.91%	8.01%
Basic Earnings Per Share	$2.19	$2.14
Diluted Earnings Per Share	$2.18	$2.13
COMMON SHARES
Basic Shares Outstanding	80.55M shares	80.51M shares
Diluted Shares Outstanding	81.00M shares	81.00M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$208.8M	$185.7M
YoY Change	-40.56%
Cash & Equivalents	$208.8M	$185.7M
Short-Term Investments
Other Short-Term Assets	$250.5M	$250.6M
YoY Change	14.8%
Inventory	$979.9M	$972.5M
Prepaid Expenses
Receivables	$1.529B	$1.478B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.968B	$2.887B
YoY Change	-0.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.590B	$1.598B
YoY Change	1.56%
Goodwill	$1.990B	$1.994B
YoY Change	5.42%
Intangibles	$800.9M	$823.8M
YoY Change	-3.87%
Long-Term Investments
YoY Change
Other Assets	$949.7M	$837.2M
YoY Change	14.62%
Total Long-Term Assets	$5.330B	$5.368B
YoY Change	1.86%
TOTAL ASSETS
Total Short-Term Assets	$2.968B	$2.887B
Total Long-Term Assets	$5.330B	$5.368B
Total Assets	$8.298B	$8.255B
YoY Change	0.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.313B	$1.302B
YoY Change	6.24%
Accrued Expenses	$235.4M	$203.4M
YoY Change	25.21%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.172B	$1.171B
YoY Change	80.83%
Total Short-Term Liabilities	$3.300B	$3.308B
YoY Change	24.83%
LONG-TERM LIABILITIES
Long-Term Debt	$2.047B	$2.070B
YoY Change	-29.69%
Other Long-Term Liabilities	$664.4M	$673.1M
YoY Change	80.79%
Total Long-Term Liabilities	$2.711B	$2.743B
YoY Change	-17.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.300B	$3.308B
Total Long-Term Liabilities	$2.711B	$2.743B
Total Liabilities	$6.011B	$6.051B
YoY Change	-2.72%
SHAREHOLDERS EQUITY
Retained Earnings	$4.922B	$4.809B
YoY Change	9.71%
Common Stock	$957.2M	$958.1M
YoY Change	-1.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.287B	$2.204B
YoY Change
Total Liabilities & Shareholders Equity	$8.298B	$8.255B
YoY Change	0.92%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$176.8M	$172.4M
YoY Change	45.87%
Depreciation, Depletion And Amortization	$78.60M	$49.00M
YoY Change	75.45%
Cash From Operating Activities	$197.7M	$119.8M
YoY Change	10305.26%
INVESTING ACTIVITIES
Capital Expenditures	$53.50M	$48.80M
YoY Change	-17.05%
Acquisitions
YoY Change
Other Investing Activities	-$3.300M	-$6.300M
YoY Change	-92.95%
Cash From Investing Activities	-$56.80M	-$62.00M
YoY Change	-51.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-117.1M	-$85.00M
YoY Change	-139.06%
NET CHANGE
Cash From Operating Activities	197.7M	$119.8M
Cash From Investing Activities	-56.80M	-$62.00M
Cash From Financing Activities	-117.1M	-$85.00M
Net Change In Cash	23.80M	-$29.30M
YoY Change	-87.07%
FREE CASH FLOW
Cash From Operating Activities	$197.7M	$119.8M
Capital Expenditures	$53.50M	$48.80M
Free Cash Flow	$144.2M	$71.00M
YoY Change	-330.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#Assets
CY2024Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#LiabilitiesAndStockholdersEquity
CY2024Q1	us-gaap	Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration	http://www.averydennison.com/20240330#LongTermRetirementBenefitsAndOtherLiabilities
CY2023Q4	us-gaap	Environmental Loss Contingency Current Statement Of Financial Position Extensible Enumeration EnvironmentalLossContingencyCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2024Q1	us-gaap	Environmental Loss Contingency Current Statement Of Financial Position Extensible Enumeration EnvironmentalLossContingencyCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1519100000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1522700000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	632200000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	542300000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	365200000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	334400000	usd
CY2024Q1	avy	Other Expense Income Net OtherExpenseIncomeNet	12600000	usd
CY2023Q2	avy	Other Expense Income Net OtherExpenseIncomeNet	17800000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	28600000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	26400000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8600000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4600000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	234400000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	168300000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	62000000.0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47100000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	172400000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	121200000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.14
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.50
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.13
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80500000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80900000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81000000.0	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81500000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	172400000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	121200000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-11900000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	400000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-200000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	200000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-2200000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	2800000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-13900000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3000000.0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	158500000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	124200000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	172400000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	121200000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	49000000.0	usd
CY2023Q2	us-gaap	Depreciation Depreciation	44800000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	28300000	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	27500000	usd
CY2024Q1	avy	Accounts Receivable Credit Loss Expense Reversal And Sales Returns AccountsReceivableCreditLossExpenseReversalAndSalesReturns	11800000	usd
CY2023Q2	avy	Accounts Receivable Credit Loss Expense Reversal And Sales Returns AccountsReceivableCreditLossExpenseReversalAndSalesReturns	10600000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7500000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	10500000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3000000.0	usd
CY2023Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-4500000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-18100000	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-10100000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	164300000	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	218300000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	119800000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1900000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48800000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64500000	usd
CY2024Q1	avy	Purchase Of Software And Other Deferred Charges PurchaseOfSoftwareAndOtherDeferredCharges	6900000	usd
CY2023Q2	avy	Purchase Of Software And Other Deferred Charges PurchaseOfSoftwareAndOtherDeferredCharges	5300000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	20200000	usd
CY2023Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	14000000.0	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	100000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	200000	usd
CY2024Q1	avy	Proceeds From Insurance And Sales Purchases Of Investments Net ProceedsFromInsuranceAndSalesPurchasesOfInvestmentsNet	100000	usd
CY2023Q2	avy	Proceeds From Insurance And Sales Purchases Of Investments Net ProceedsFromInsuranceAndSalesPurchasesOfInvestmentsNet	-3500000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	300000	usd
CY2023Q2	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	43500000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-62000000.0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-116600000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	15900000	usd
CY2023Q2	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	42900000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	0	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Long Term Debt And Capital Securities Net ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet	394900000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	1700000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	1400000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	65300000	usd
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	60800000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	88400000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15600000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50700000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	18300000	usd
CY2023Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	23600000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1500000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-85000000.0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	299800000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2100000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1000000.0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29300000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	184100000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	215000000.0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	167200000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	185700000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	351300000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2013600000	usd
CY2024Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-3000000.0	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-16900000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	1993700000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22400000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20500000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	66800000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	85600000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	85200000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	77400000	usd
CY2024Q1	avy	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	265500000	usd
CY2024Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	3080000000.00	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	3110000000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	27700000	usd
CY2024Q1	avy	Restructuring Settlement And Impairment Provisions Net Of Reversals RestructuringSettlementAndImpairmentProvisionsNetOfReversals	6000000.0	usd
CY2024Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	13200000	usd
CY2024Q1	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	700000	usd
CY2024Q1	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	500000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	19300000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	124100000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.75
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.81
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	234400000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	168300000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	62000000.0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47100000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.265
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.280
CY2024Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	6000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	172400000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	121200000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80500000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80900000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	500000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	600000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81000000.0	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81500000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.14
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.50
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.13
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	124100000	usd
CY2024Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-14500000	usd
CY2024Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-600000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-13900000	usd
CY2023Q2	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	2200000	usd
CY2023Q2	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-800000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3000000.0	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	68000000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	71000000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	2200000	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	0	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	0	usd
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	Commitments and Contingencies <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are involved in various lawsuits, claims, inquiries and other regulatory and compliance matters, most of which are routine to the nature of our business. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these claims could affect future results of operations should our exposure be materially different from our estimates or should we incur liabilities that were not previously accrued. Potential insurance reimbursements are not offset against potential liabilities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We were party to a litigation in which ADASA Inc. (“Adasa”), an unrelated third party, alleged that certain of our RFID products within our Solutions Group reportable segment infringed its patent. The case was filed on October 24, 2017 in the United States District Court in the District of Oregon (Eugene Division) and was captioned ADASA Inc. v. Avery Dennison Corporation. We recorded a contingent liability in the amount of $26.6 million related to this matter in the second quarter of 2021 based on a jury verdict issued on May 14, 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We appealed the first instance judgment associated with the jury verdict – which resulted in additional potential liability for the RFID tags sold during the period from the jury verdict to the issuance of the first instance judgment, a higher royalty imposed by the judge applicable to tags sold after the judgment and a royalty on additional late-disclosed tags, as well as sanctions, prejudgment interest, costs, and attorneys’ fees, as well as an ongoing royalty on in-scope tags sold after October 14, 2021 – to the United States Court of Appeals for the Federal Circuit (the “CAFC”). During the fourth quarter of 2022, the CAFC issued its opinion, reversing the grant of summary judgment of validity as to anticipation and obviousness, vacating the sanctions ruling, and remanding the case for retrial with respect to validity for anticipation and obviousness over the prior art. The CAFC affirmed subject-matter eligibility and damages if liability was </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">determined on retrial. On remand, the trial court was required to reconsider the amount of sanctions consistent with the CAFC's instruction to limit sanctions to the late-disclosed tags. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">After the U.S. Supreme Court denied our writ of certiorari petition on May 30, 2023, the trial court’s retrial began on July 10, 2023. On July 18, 2023, the jury in the retrial issued a verdict that Adasa’s patent is valid. We increased our contingent liability to reflect our then-best estimate of the anticipated judgment to $80.4 million as of July 1, 2023, with an expectation to continue adjusting our accrual quarterly, as appropriate. As of December 30, 2023, our contingent liability for this matter was $82.9 million. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 25, 2024, the district court issued a revised sanction order lowering the sanction against us from approximately $20 million to $5.2 million, based on a rate of $0.0025/late-reported tag, which was consistent with the amount we had accrued. In February 2024, the district court issued its decision denying our motion for judgment as a matter of law and our motion for a new trial. On March 7, 2024, the Court issued an amended final judgment, assessing damages, pre- and post-judgment interest, costs, attorneys' fees, sanctions, and on-going royalties.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsequent to the end of the first quarter of 2024, on April 25, 2024, we executed a Settlement Agreement, License and Mutual Release with Adasa pursuant to which, among other things, (i) we agreed to pay $75.0 million to Adasa without any concessions or admissions of liability; (ii) Adasa agreed to grant us a worldwide, nonexclusive, nontransferable fully-paid up, and ongoing royalty-free perpetual license, without the right to sublicense, to the patents at issue in the litigation; and (iii) the parties mutually released all claims against one another. We paid the agreed-upon settlement amount to Adasa on April 26, 2024. No court approval of the settlement is required, however, as required by the settlement agreement, Adasa filed a Stipulation of Satisfaction of Judgment with the trial court on April 29, 2024. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve legal proceedings could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses determined to be probable in an amount higher or lower than what we have accrued, we would adjust our accrued liabilities accordingly. Additional lawsuits, claims, inquiries and other regulatory and compliance matters could arise in the future. The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for their resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of legal proceedings would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Environmental Expenditures </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Environmental expenditures are generally expensed. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these matters could affect future results of operations should our exposure be materially different from our estimates or should we incur liabilities that were not previously accrued. Potential insurance reimbursements are not offset against potential liabilities. We review our estimates of the costs of complying with environmental laws related to remediation and cleanup of various sites, including sites in which governmental agencies have designated us as a potentially responsible party (“PRP”). However, environmental expenditures for newly acquired assets and those that extend or improve the economic useful life of existing assets are capitalized and amortized over the shorter of the estimated useful life of the acquired asset or the remaining life of the existing asset. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March 30, 2024, we have been designated by the U.S. Environmental Protection Agency (“EPA”) and/or other responsible state agencies as a PRP at eleven waste disposal or waste recycling sites that are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination. No settlement of our liability related to any of these sites has been agreed upon. We are participating with other PRPs at these sites and anticipate that our share of remediation costs will be determined pursuant to agreements that we negotiate with the EPA or other governmental authorities. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors. Because of the uncertainties associated with environmental assessment and remediation activities, our future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses determined to be probable. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly. In addition, we may be identified as a PRP at additional sites in the future. The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for their remediation cannot be determined. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The activity related to our <span style="-sec-ix-hidden:f-450">environmental liabilities</span> for the three months ended March 30, 2024 is shown below. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 30, 2023</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges, net of reversals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 30, 2024</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.0 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Approximately $9 million and $11 million, respectively, of this balance was classified as short-term and included in “<span style="-sec-ix-hidden:f-457"><span style="-sec-ix-hidden:f-458">Other current liabilities</span></span>” in the unaudited Condensed Consolidated Balance Sheets as of March 30, 2024 and December 30, 2023.</span></div>
CY2024Q1	avy	Environmental Potentially Responsible Party Number Of Sites EnvironmentalPotentiallyResponsiblePartyNumberOfSites	11	site
CY2023Q4	us-gaap	Accrual For Environmental Loss Contingencies AccrualForEnvironmentalLossContingencies	24500000	usd
CY2024Q1	avy	Environmental Charges Net Of Reversals EnvironmentalChargesNetOfReversals	500000	usd
CY2024Q1	us-gaap	Accrual For Environmental Loss Contingencies Payments1 AccrualForEnvironmentalLossContingenciesPayments1	2000000.0	usd
CY2024Q1	us-gaap	Accrual For Environmental Loss Contingencies AccrualForEnvironmentalLossContingencies	23000000.0	usd
CY2024Q1	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	9000000	usd
CY2023Q4	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	11000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2151300000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2065000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	28600000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	26400000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8600000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4600000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	234400000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	168300000	usd
CY2024Q1	avy	Other Expense Income Net OtherExpenseIncomeNet	12600000	usd
CY2023Q2	avy	Other Expense Income Net OtherExpenseIncomeNet	17800000	usd
CY2024Q1	avy	Loss Gain From Foreign Currency Remeasurement And Marketable Securities Transaction LossGainFromForeignCurrencyRemeasurementAndMarketableSecuritiesTransaction	11300000	usd
CY2023Q2	avy	Loss Gain From Foreign Currency Remeasurement And Marketable Securities Transaction LossGainFromForeignCurrencyRemeasurementAndMarketableSecuritiesTransaction	0	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2200000	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2024Q1	avy	Loss Gain Related To Outcomes Of Legal Matters And Settlements Net LossGainRelatedToOutcomesOfLegalMattersAndSettlementsNet	-6900000	usd
CY2023Q2	avy	Loss Gain Related To Outcomes Of Legal Matters And Settlements Net LossGainRelatedToOutcomesOfLegalMattersAndSettlementsNet	0	usd
CY2024Q1	avy	Transaction And Related Costs TransactionAndRelatedCosts	0	usd
CY2023Q2	avy	Transaction And Related Costs TransactionAndRelatedCosts	200000	usd
CY2024Q1	avy	Other Expense Income Net OtherExpenseIncomeNet	12600000	usd
CY2023Q2	avy	Other Expense Income Net OtherExpenseIncomeNet	17800000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	404400000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	415400000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	230900000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	238200000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	337200000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	267100000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	972500000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	920700000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3923900000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3970400000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2325700000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2344600000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1598200000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1625800000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	34400000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	34400000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1700000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1400000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1300000	usd
CY2024Q1	avy	Accounts Receivable Allowance For Credit Loss Foreign Currency Translation And Other Net AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAndOtherNet	-100000	usd
CY2023Q2	avy	Accounts Receivable Allowance For Credit Loss Foreign Currency Translation And Other Net AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAndOtherNet	700000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	34600000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	33900000	usd
CY2024Q1	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	383000000	usd
CY2023Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	397400000	usd
CY2024Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-6000000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000008818-24-000009-index-headers.html	Edgar Link	pending
0000008818-24-000009-index.html	Edgar Link	pending
0000008818-24-000009.txt	Edgar Link	pending
0000008818-24-000009-xbrl.zip	Edgar Link	pending
avy-20240330.htm	Edgar Link	pending
avy-20240330.xsd	Edgar Link	pending
avy-20240430x10qex311.htm	Edgar Link	pending
avy-20240430x10qex312.htm	Edgar Link	pending
avy-20240430x10qex321.htm	Edgar Link	pending
avy-20240430x10qex322.htm	Edgar Link	pending
avy-20244030x10qex101.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
avy-20240330_cal.xml	Edgar Link	unprocessable
avy-20240330_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
avy-20240330_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
avy-20240330_lab.xml	Edgar Link	unprocessable
avy-20240330_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVY
Avery Dennison Corp Stock $avy

2024 Q2 Form 10-Q Financial Statement

#000000881824000009 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVY Avery Dennison Corp Stock $avy

2024 Q2 Form 10-Q Financial Statement

#000000881824000009 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVY
Avery Dennison Corp Stock $avy